About Total Research Group, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Ardelyx
1
Frank C Sciurba
1
Palladio Biosciences
1
Clinical Trials at Total Research Group, LLC
During the past decade, Total Research Group, LLC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
2019-01-31
2025-01-31
Active, not recruiting
6,609
Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
2019-02-28
2019-07-17
Completed
236
Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
2021-10-28
2022-08-03
Terminated
12
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
2020-09-07
2021-08-05
Terminated
657
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
2022-01-11
2023-07-04
Active, not recruiting
714
A Study to Test BI 764198 in People With a Type of Kidney Disease Called Primary Focal Segmental Glomerulosclerosis
2022-03-10
2025-02-21
Recruiting
60
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Total Research Group, LLC"
#1 collaborator was "Centessa Pharmaceuticals plc" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Total Research Group, LLC
According to Clinical.Site data, the most researched conditions in "Total Research Group, LLC" are
"Kidney Disease, Chronic" (2 trials), "ADPKD" (1 trials), "Autosomal Dominant Polycystic Kidney" (1 trials), "COVID-19" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Total Research Group, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Total Research Group, LLC
Most popular intervention types in "Total Research Group, LLC" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Apixaban 2.5 MG" (1 trials), "Apixaban 5MG" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Total Research Group, LLC
The vast majority of trials in "Total Research Group, LLC" are
6 trials for "All" genders.
Clinical Trials Status at Total Research Group, LLC
Currently, there are NaN active trials in "Total Research Group, LLC".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Total Research Group, LLC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Total Research Group, LLC, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".